Myocardial Ischemia Induces SDF-1α Release in Cardiac Surgery Patients
Bong-Sung Kim1, Denise Jacobs2, Christoph Emontzpohl2
1Department of Plastic Surgery, Hand Surgery, Burn Center, RWTH Aachen University, Aachen, Germany.
Insights
Serum levels of stromal cell-derived factor-1α (SDF-1α) significantly increase during myocardial ischemia in cardiac surgery patients. Higher SDF-1α levels may indicate reduced organ dysfunction, suggesting potential organoprotective roles.
Area of Science:
- Cardiology
- Biochemistry
- Surgical Research
Background:
- Cardiac surgery with cardiopulmonary bypass presents risks of myocardial injury and organ dysfunction.
- Stromal cell-derived factor-1α (SDF-1α) is a chemokine implicated in inflammation and tissue repair.
- Understanding biomarkers of myocardial injury is crucial for patient management.
Purpose of the Study:
- To measure serum levels of SDF-1α during cardiac surgery.
- To investigate the relationship between SDF-1α levels and myocardial ischemia/reperfusion.
- To explore the association between SDF-1α and perioperative organ dysfunction.
Main Methods:
- Observational study of 100 patients undergoing cardiac surgery with cardiopulmonary bypass.
- Serum SDF-1α levels measured at seven time points: pre-operative, ischemia, reperfusion, and post-operative.
- Explorative analysis of SDF-1α association with patient characteristics and organ dysfunction incidence.
Main Results:
- Myocardial ischemia significantly increased serum SDF-1α levels; reperfusion had no significant effect.
- Perioperative SDF-1α levels were influenced by patient factors like age, gender, and aspirin use.
- An inverse association was observed between SDF-1α levels and the incidence of organ dysfunction.
Conclusions:
- Myocardial ischemia is a key stimulus for SDF-1α upregulation, marking it as a marker of myocardial injury.
- The inverse association suggests SDF-1α may have organoprotective properties in cardiac surgery.
- Further research is warranted to evaluate SDF-1α's organoprotective potential in this patient cohort.
Abstract:
In the present observational study, we measured serum levels of the chemokine stromal cell-derived factor-1α (SDF-1α) in 100 patients undergoing cardiac surgery with cardiopulmonary bypass at seven distinct time points including preoperative values, myocardial ischemia, reperfusion, and the postoperative course. Myocardial ischemia triggered a marked increase of SDF-1α serum levels whereas cardiac reperfusion had no significant influence. Perioperative SDF-1α serum levels were influenced by patients' characteristics (e.g., age, gender, aspirin intake). In an explorative analysis, we observed an inverse association between SDF-1α serum levels and the incidence of organ dysfunction. In conclusion, time of myocardial ischemia was identified as the key stimulus for a significant upregulation of SDF-1α, indicating its role as a marker of myocardial injury. The inverse association between SDF-1α levels and organ dysfunction association encourages further studies to evaluate its organoprotective properties in cardiac surgery patients.
